MIM
FTXH icon

Marshall Investment Management’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Marshall Investment Management’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.55M Buy
45,232
+3,423
+8% +$117K 0.75% 45
2025
Q4 		$1.38M Buy
+41,809
New +$1.3M 0.69% 43

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Marshall Investment Management's FTXH Position: Q1 2026 in Review

Marshall Investment Management increased its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 8.2% in Q1 2026, buying an estimated $117K and bringing the position to 45,232 shares worth $1.55M. The position accounts for 0.75% of the portfolio, ranked #45.

Marshall Investment Management first reported a position in FTXH in Q4 2025 and has held it in 2 quarters since. 32 funds tracked by Wall St. Rank hold FTXH as of Q1 2026.

  • Marshall Investment Management held 45,232 shares of First Trust Nasdaq Pharmaceuticals ETF worth $1.55M as of Q1 2026.
  • Marshall Investment Management bought 3,423 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2026, an estimated $117K.
  • First Trust Nasdaq Pharmaceuticals ETF made up 0.75% of Marshall Investment Management's portfolio in Q1 2026, its #45 holding.
  • Marshall Investment Management first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2025 and has held it in 2 quarters since.
  • 32 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2026.

Based on Marshall Investment Management's 13F filing for Q1 2026, filed 8 May 2026.